Daily meet celebrity with new activity
p53: Guardian of the Genome
p53 in cell cycle regulation | p53 and cancer | p53 tumor suppressor.
NEOPLASIA 4: p53 gene: The Guardian of the genome. functions, regulation and inactivation
Is TP53-mutated high-risk MDS the same disease as TP53-mutated AML?
The Role of p53 in Cancer
p53 Tumour Suppressor and MDM2
Treatment options for patients with TP53-mutated AML
p53 Tumour Suppressor (2016) by Etsuko Uno wehi.tv
Valorant - Towards the radiant / Rumo ao radiante. P53
Challenges in treating patients with TP53-mutated AML and future outlooks
Should patients with TP53-mutated MDS receive stem cell transplant?
Is there hope for treating TP53-mutated MDS?
Progress in the treatment of TP53 mutated AML
Current knowledge of the TP53 mutation and its role in CLL
The importance of targeting TP53 in AML and agents being explored
Removing the Most Common P53 Mutation in Colorectal Cancer Halts Disease Progression
The impact of p53 mutation on survival in EGFR-mutated NSCLC patients
An analysis of TP53 mutation in AML and HR-MDS
Identifying low-burden TP53 mutations with NGS in CLL
The challenges of treating TP53-mutated AML and MDS
The benefit of allogeneic transplantation in patients with TP53-mutated AML
The importance of TP53 in CLL
Tolerability and efficacy of magrolimab plus azacitidine in TP53-mutated AML patients
Outcomes of alloHSCT in TP53-mutated AML and MDS
Testing for IgHV and TP53 mutations to guide treatment decisions in CLL
The P53 Gene
Dr. Pemmaraju on the Challenges of Targeting TP53 Mutations in MDS/AML
ERIC recommendations on TP53 mutation classification
Aziz Nazha, MD: How Do TP53 Mutation Characteristics Affect MDS Outcomes?
Dr. Eskelund on Outcomes of TP53-Mutated MCL
Treatment recommendations for patients with CLL with del(17p) and TP53 aberrations
APR-246 in TP53 mutated MDS and AML
TP53 Testing Should Be Expanded | Ambry Genetics
TP53 mutations in CLL: a large retrospective analysis
Immunological impact of TP53 in MDS
Challenges in treating patients with TP53-mutated MCL & promising novel therapies being explored
Treatment approaches for patients with TP53-mutated MCL
Discovering the p53 cancer protein - Cancer Research UK
Evo-Ed: Breast Cancer and the TP53 Gene
TP53 and Deletion 17p as Prognostic Factors in CLL
The prognostic impact of TP53 mutation in MPNs
The impact of TP53 mutation on treatment approaches in MCL
Eprenetapopt plus venetoclax and azacitidine in the treatment of TP53-mutated AML
The role of TP53 in CLL
The importance of TP53 testing in CLL
TP53 Genetic Test
Outcomes of TP53-mutant AML with venetoclax and decitabine
HER2-enriched breast cancer: TP53 mutations and response to aromatase inhibitors
The Role of p53 and MDM2 in Cancer Growth
Dr. Landen Discusses p53 Mutations in Ovarian Cancer